TSE:141A stock news
This page provides real-time market news, earnings updates, and company announcements related to TRIAL Holdings.Inc. (TSE:141A).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-22 01:58 JST
Eli Lilly (LLY) Announces Positive Phase 3b Results for Taltz and Zepbound Combination Treatment in Psoriasis and Obesity
Finviz2026-02-20 00:30:06
Comcast Corporation (CMCSA) Reports Positive Results From Quantum Computing Trial
Finviz2026-02-20 08:36:08
Pfizer Inc (PFE) Announces Positive Results from BREAKWATER Trial
Finviz2026-02-20 08:39:45
Insmed (INSM) Poised for 2026 Upside With Potential $1.3B Arikayce Sales Boost, Roth/MKM Initiates Buy
Finviz2026-02-20 08:48:36
Genmab (GMAB) Reports 19% Revenue Growth to $3.7B in 2025 Driven by Proprietary Medicine Sales
Finviz2026-02-20 09:12:44
Why Grail Stock Is Sinking Friday
Finviz2026-02-20 10:21:41
Why Is Candel Therapeutics Stock Falling Friday?
Finviz2026-02-20 10:57:05
Ardelyx Lead Drug Growth Fails To Lift Sentiment, Stock Drops
Finviz2026-02-20 11:54:48
Fennec Pharmaceuticals Presents Real World Data Supporting the Integration and Clinical Use of PEDMARK in Treating Adults with Head & Neck Cancers
Finviz2026-02-20 12:06:46
FDA Approval For AbbVie/AstraZeneca's Combination Treatment Could Set New Standard For Slow Growing Blood Cancer
Finviz2026-02-20 13:06:49
PDS Biotech Announces Adoption of Amended Protocol for Phase 3 VERSATILE-003 Trial Incorporating Progression Free Survival (PFS) as Primary Endpoint for Interim Analysis and Potential Accelerated Approval
Finviz2026-02-20 13:33:46
PDS Biotechnology Corporation (PDS Biotech) recently announced that it has made significant amendments to the study protocol of its Phase III clinical trial, Versatile-003.
老虎证券2026-02-20 13:40:05
Senti Bio Participates in Cell & Gene Live Event Highlighting Cutting-Edge Technologies Advancing Cell Therapy Development
Finviz2026-02-20 13:51:55
Stock Futures Slide as Q4 GDP Misses Estimates
Finviz2026-02-20 14:21:04
US judge upholds $243 million verdict against Tesla over fatal Autopilot crash
101 finance2026-02-20 14:45:08
Magic Mushrooms, Hard Cash: Compass Pathways' Trial Win, Fast Raise
Finviz2026-02-20 16:15:09
Caribou Biosciences (CRBU)'s CB-011 May Reach $734 Million in Peak 2040 Sales, According to Clear Street
Finviz2026-02-20 17:00:48
Strong Analyst Confidence in C4 Therapeutics (CCCC)'s Cemsidomide Drives 270% Upside Potential
Finviz2026-02-20 17:03:42
Geopolitical Tensions Resurface Amid Volatile Week
Finviz2026-02-20 19:12:51
U.S. Food and Drug Administration (FDA) Accepts Teva's New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults
Finviz2026-02-20 19:48:38
Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option
Finviz2026-02-20 20:15:41
Abbott Laboratories (ABT) Announces Positive Results for Amulet 360 Left Atrial Appendage (LAA) Occlude
Finviz2026-02-20 20:15:42
Top 20 US Stocks by Trading Volume on February 21: Nvidia Reportedly Close to Investing $30 Billion in OpenAI
新浪财经2026-02-20 21:47:53
Morgan Stanley Lowers its Price Target on IQVIA Holdings Inc. (IQV) to $240 but Maintains an Overweight Rating
Finviz2026-02-21 15:39:41
Genmab (GMAB) Reports 19% Revenue Growth to $3.7B in 2025 Driven by Proprietary Medicine Sales
Finviz2026-02-20 09:12:44
Why Grail Stock Is Sinking Friday
Finviz2026-02-20 10:21:41
Why Is Candel Therapeutics Stock Falling Friday?
Finviz2026-02-20 10:57:05
Ardelyx Lead Drug Growth Fails To Lift Sentiment, Stock Drops
Finviz2026-02-20 11:54:48
Fennec Pharmaceuticals Presents Real World Data Supporting the Integration and Clinical Use of PEDMARK in Treating Adults with Head & Neck Cancers
Finviz2026-02-20 12:06:46
FDA Approval For AbbVie/AstraZeneca's Combination Treatment Could Set New Standard For Slow Growing Blood Cancer
Finviz2026-02-20 13:06:49
PDS Biotech Announces Adoption of Amended Protocol for Phase 3 VERSATILE-003 Trial Incorporating Progression Free Survival (PFS) as Primary Endpoint for Interim Analysis and Potential Accelerated Approval
Finviz2026-02-20 13:33:46
PDS Biotechnology Corporation (PDS Biotech) recently announced that it has made significant amendments to the study protocol of its Phase III clinical trial, Versatile-003.
老虎证券2026-02-20 13:40:05
Senti Bio Participates in Cell & Gene Live Event Highlighting Cutting-Edge Technologies Advancing Cell Therapy Development
Finviz2026-02-20 13:51:55
Stock Futures Slide as Q4 GDP Misses Estimates
Finviz2026-02-20 14:21:04
US judge upholds $243 million verdict against Tesla over fatal Autopilot crash
101 finance2026-02-20 14:45:08
Magic Mushrooms, Hard Cash: Compass Pathways' Trial Win, Fast Raise
Finviz2026-02-20 16:15:09
Caribou Biosciences (CRBU)'s CB-011 May Reach $734 Million in Peak 2040 Sales, According to Clear Street
Finviz2026-02-20 17:00:48
Strong Analyst Confidence in C4 Therapeutics (CCCC)'s Cemsidomide Drives 270% Upside Potential
Finviz2026-02-20 17:03:42
Geopolitical Tensions Resurface Amid Volatile Week
Finviz2026-02-20 19:12:51
U.S. Food and Drug Administration (FDA) Accepts Teva's New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults
Finviz2026-02-20 19:48:38
Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option
Finviz2026-02-20 20:15:41
Abbott Laboratories (ABT) Announces Positive Results for Amulet 360 Left Atrial Appendage (LAA) Occlude
Finviz2026-02-20 20:15:42
Top 20 US Stocks by Trading Volume on February 21: Nvidia Reportedly Close to Investing $30 Billion in OpenAI
新浪财经2026-02-20 21:47:53
Morgan Stanley Lowers its Price Target on IQVIA Holdings Inc. (IQV) to $240 but Maintains an Overweight Rating
Finviz2026-02-21 15:39:41
TSE:141A stock price change
On the last trading day, TSE:141A stock closed at 3890.00 JPY, with a price change of 21.94% for the day.
Trade stock futuresTSE:141A stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more